Jeffrey Trigilio
2020
In 2020, Jeffrey Trigilio earned a total compensation of $1.7M as Chief Financial Officer at Cullinan Therapeutics.
Compensation breakdown
| Bonus | $53,168 |
|---|---|
| Option Awards | $1,566,488 |
| Salary | $118,029 |
| Total | $1,737,685 |
Trigilio received $1.6M in option awards, accounting for 90% of the total pay in 2020.
Trigilio also received $53.2K in bonus and $118K in salary.
Rankings
In 2020, Jeffrey Trigilio's compensation ranked 6,175th out of 13,090 executives tracked by ExecPay. In other words, Trigilio earned more than 52.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,175 out of 13,090 | 53rd |
Division Manufacturing | 2,552 out of 5,624 | 55th |
Major group Chemicals And Allied Products | 1,028 out of 2,257 | 55th |
Industry group Drugs | 887 out of 1,957 | 55th |
Industry Biological Products, Except Diagnostic Substances | 215 out of 411 | 48th |
Source: SEC filing on April 29, 2022.
Trigilio's colleagues
We found two more compensation records of executives who worked with Jeffrey Trigilio at Cullinan Therapeutics in 2020.